Focus Meeting 5
MOLECULAR IMAGING AND THERANOSTICS
IN PROSTATE CANCER –
THE FUTURE BEGINS TODAY
February 2-4, 2023
We are delighted to announce that the consensus paper from the EANM Focus Meeting 5 entitled ‘European Association of Nuclear Medicine Focus 5: Consensus on Molecular Imaging and Theranostics in Prostate Cancer’ has been published in the European Urology.
This publication results from the collaborative effort of all the panellists who contributed their expertise and knowledge to the discussion.
EANM Focus Meeting 5 Trailer
We express our sincere gratitude to the following companies for their sponsorship engagement:
Advanced Accelerator Applications
A Novartis Company
|Spectrum Dynamics Medical Ltd.
|Blue Earth Diagnostics
|ITM Isotope Technologies Munich SE